Product Name:Degarelix
Cas No.:214766-78-6
Appearance:White powder
Molecular Formula:C82H103ClN18O16
Molar Mass:1632.28 g/mol
Purity:98%
Storage conditions:Stable at normal temperatures and pressures.
Degarelix (INN) or degarelix acetate (USAN) is a hormonal therapy used in the treatment of prostate cancer. During development it was known as FE200486.Testo sterone is a male hormone that promotes growth of many prostate tumours and therefore reducing circulating testo sterone to very low (castration) levels is often the treatment goal in the management of advanced prostate cancer. Degarelix has an immediate onset of action, binding to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and
blocking their interaction with GnRH. This induces a fast and profound reduction in luteinising hormone (LH), follicle-stimul-ating hormone (FSH) and in turn, testo sterone suppression.
Function and Application
Cetrorelix acetate is an injectable gonadotropin-releasing hormone (GnRH) antagonist. A synthetic decapeptide, it is used to treathormone-sensitive cancers of the prostate and breast (in pre-/perimenopausal women) and some benign gynaecological disorders(endometriosis, uterine fibroids and endometrial thinning).
China
